Knowledge and Attitude about Multidrug-Resistant Tuberculosis among Healthcare Workers in Public Health Centres by Lestari, Bony Wiem & Soeroto, Arto Yuwono
Althea Medical Journal. 2016;3(4)
509
Knowledge and Attitude about Multidrug-Resistant Tuberculosis 
among Healthcare Workers in Public Health Centres 
Bony Wiem Lestari,1 Arto Yuwono Soeroto21Department of Public Health Faculty of Medicine Universitas Padjadjaran, 3Department of Internal Medicine Faculty of Medicine Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital Bandung
Abstract
Background: Multidrug-resistant Tuberculosis (MDR-TB) is a significant public health problem and poses 
a threat to global tuberculosis (TB) control. In 2015, at least 504 new MDR-TB cases were identified in Indonesia. Treating MDR-TB patients is very challenging. It may take more than two years for MDR-TB treatment. Therefore, it is crucial healthcare workers (HCWs) are knowledgeable about MDR-TB. The aim of this study was to measure level of knowledge and attitude regarding MDR-TB among HCWs in public health centres.
Methods: A cross-sectional study was conducted at 73 Public Health Centres in Bandung the capital of West Java Province  from August until November 2015. The samples were 73 TB nurses and 32 laboratory staff. A self-administered questionnaire was given  comprising 27 knowledge questions and 29 attitude questions. Correlation between knowledge and attitude scores was calculated by Pearson correlation test.
Results: The majority of study participants were women (82.9%), married (92.4%), nursing staff (65.7%) with history of TB training (98.1%). Most of the participants were  40-59 years old (69.5%) with working experience in TB programme < 10 years (69.5%). Less than half (38.1%) of study participants had good knowledge. In terms of attitude, more than half (53.3%) of study participants had a positive attitude towards MDR-TB.
Conclusions: The level of knowledge among HCWs about MDR-TB is still at an unacceptable level. Certain educational interventions aim to ensure prompt diagnosis, implement infection control and accurate treatment should be established among those HCWs. [AMJ.2016;3(4):509–13]
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IntroductionTuberculosis (TB) is still a major health problem in the world. It has become one of the top ten causes of death worldwide in 2015.1 Mycobacterium tuberculosis, as a causative agent of TB, is mostly  susceptible to isoniazid (INH) and rifampin (RIF) which both are known to be the most powerful antituberculosis drugs. Strains of Mycobacterium tuberculosis which are resistant to these drugs, are termed as multidrug-resistant TB(MDR-TB). Currently, 
MDR-TB posed a significant thread to global TB control.2In 2010, the World Health Organization (WHO) recommended the utilisation of Xpert MTB Rif (Xpert) as a new automated molecular diagnostic test to rapidly identify Rifampicin 
Resistant-TB which can be a good proxy for MDR-TB.3 The use of Xpert is upscaled globally since it provides accurate results for RIF-resistance detection given pending results from conventional culture and drug-susceptibility testing (DST).4 As part of the Indonesian National TB Programme (NTP), efforts to upscale programmatic management of drug-resistant TB (PMDT), Xpert is used as a routine test for presumptive MDR-TB patients.5Treating MDR-TB patients is very challenging since it has a longer course of treatment, more severe side effects, and is more 
toxic, more difficult to acquire and much more expensive. Furthermore, it may take more than two years for MDR-TB treatment which leads to social isolation, loss of employment, socio-economic crisis and psychosocial burden.6
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In 2015, at least 504 new MDR-TB cases 
were identified in Indonesia. Based on this alarming condition, it is crucial that healthcare providers in Indonesia are knowledgeable about MDR-TB and certain measures to control its transmission. To control MDR-TB outbreak, prompt diagnosis, infection control and effective treatment are imperative. In general, it is assumed that healthcare workers (HCWs) especially the TB nurse know about MDR-TB and its consequences. However, evidence showed that HCWs do not always have enough knowledge or the proper positive attitude; and do not consistently present correct practices about prevention and treatment about MDR-TB.7Until now, no study has been found assessing the knowledge and attitude regarding MDR-TB among HCWs in Indonesia. Therefore, this study aimed to measure knowledge and attitude about MDR-TB amongst HCWs working at public health centers in Bandung Municipality. 
MethodsThis was a cross-sectional study in Bandung Municipality, an urban city that served as a capital city of West Java which has approximately 2.5 millions inhabitants. The city has 73 public health centers which almost half of them (30 out of 73) are equipped with a microscopy laboratory. The study population were TB nurses and laboratory staff working at public health centres within Bandung area. In this study, our sample comprised of 73 TB nurses and 32 laboratory staff. This study was carried out from August until November 2015. 
A modified questionnaire was developed based on WHO treatment guidelines for drug-resistant TB and national guidelines for PMDT.8 The questionnaire was semi-structured and self-administered. Considering the small number of study population, a research assistant delivered the questionnaire 
and asked the study participants to fill it out. Once they had completed the questionnaires, the research assistant returned to the public health centers to collect them. Besides questions about knowledge and attitude of MDR-TB, information about sociodemographic and professional data were also collected. The level of knowledge of MDR-TB were obtained through a set of 27 questions 
about the definition of MDR-TB, referral criteria, transmission, symptoms, diagnosis and course of treatment. The knowledge level 
was classified as good if the study participants 
scored >75; fair if the score was between 56-75; and poor if the score was less than 55.Meanwhile, to assess the level of attitude towards MDR-TB, a set of 29 questions about risk factors, transmission, infection control and role of the public health centre were asked to the study participants. The study participants were categorised as having a positive attitude when they scored above the average; and a negative if they scored below the average.Furthermore, the research assistant checked the returned questionnaires for their completeness. Next, the data were captured in Microsoft Excel and imported into SPSS version 20 for data analysis. Then the categorical variables were presented in frequency and percentages. The correlation between knowledge and attitude scores was obtained by Pearson correlation test. The 
level of statistical significancy was determined when the p-value is <0.05.This study had obtained the ethics approval from the Health Research Ethics Committee Faculty of Medicine Universitas Padjadjaran number 712/UN6.C2.1.2/KEPK/PN/2014 and the permission to conduct the survey at public health centers from the Municipal Health 
Office.
ResultsOut of the 105 participants who received the questionnaire, 105 returned the completed questionnaire which provided a response rate of 100%. The majority of study participants were female (n=87; 82.9%), married (n=97; 92.4%), nursing staff (n=69; 65.7%) with history of TB training (n=103; 98.1%). The mean age of study participants was 44.84(7.73) years old with an age range from 26 to 58 years. Based on age category, most of the participants were aged  between 40-59 years  (n=73; 69.5%) with working experience in TB programme < 10 years (n=73; 69.5%) (Table 1).Regarding the knowledge of MDR-TB, less than half (38.1%) of study participants had good knowledge. Additionally, participants 
provided incorrect answers about definition of MDR-TB, how it is diagnosed, duration of treatment, role of public health centers in decentralised PMDT, and infection control. In terms of attitude, more than half (53.3%) of study participants had a positive attitude towards MDR-TB. While about 89.5% (n=94) of study participants mentioned that they were involved in providing health education about MDR-TB. Concerning the use of Xpert 
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in diagnosing TB among people living with HIV, about 73.4% (n=77) of study participants stated that they would refer HIV patients to be checked by Xpert whenever they had TB symptoms. With regard to negative attitudes, 
only 55.2% (n=58) of study participants had a correct understanding about the use of N-95 protective mask while in contact with MDR-TB patients. About 64.8% (n=68) of study participants believed that Xpert 
Table Sociodemographic Characteristics of Study Participants 
Variables Frequency (n) Percentage (%)Age category    20–29 years old 3 2.9    30–39 years old 29 27.6    40–49 years old 37 35.2    50–59 years old 36 34.3Gender    Male 18 17.1    Female 87 82.9Professional category    TB nurse 69 65.7    Midwife 6 5.7    Laboratory analyst 30 28.6Work experience category    1–5 years 32 30.5    6–10 years 41 39    11–15 years 16 15.2    15–20 years 10 9.5    >20 years 6 5.7History of TB training    Yes 103 98.1    No 2 1.9Marital status    Single 4 3.8    Married 97 92.4    Divorced 3 2.9    Widowed 1 1.0Knowledge level    Good 40 38.1    Fair 55 52.4    Poor 10 9.5Attitude level    Positive 56 53.3    Negative 49 46.7
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would be sufficient to diagnose MDR-TB. This study discovered that there was  a positive association between knowledge and attitude of 
the participants with a correlation coefficient (r) = 0.44 indicating a moderate degree of correlation between those two variables with p-value <0.01 which was statistically 
significant.
Discussion
The findings of this study showed that the majority of participants were female, middle adults and nurses. This distribution is consistent with the structure of healthcare workforce in West Java Province where 48% are nurses and mostly women (66.7%).9 In order to achieve the aim of this study, it was discouraging that only 38.1% of study participants had a good knowledge about MDR-TB. The inadequacy in knowledge were 
identified within these fields namely 1) 
definition of MDR-TB; 2) how it is diagnosed; 3) duration of its treatment; 4) role of public health centers in decentralised PMDT; and 5) infection control. These gaps were similar with 
other findings from  other investigators.10–13Based on personal characteristics of study participants such as age, gender, professional category, number of years of working experience, and history of TB training, there was no evidence from this study  demonstrating 
that there was any significant difference among study participants with regard to their knowledge and attitude about MDR-TB.
With regard to perceived benefit of using N-95 protective mask, about 44.8% of study participants reported that they felt uncomfortable using it when dealing with 
MDR-TB patients. This finding was similar with a study conducted in Georgia USA whereas only 60% of HCWs reported frequent use of respirators when in contact with TB patients.14 This perception is unacceptable since the use of N-95 mask is mandatory to prevent exposure with MDR-TB strains. Transmission of drug-resistant M. tuberculosis can cause public drug resistance among individuals with no prior history of TB, as well as among individuals with a history of prior TB treatment. Therefore, by protecting HCWs, their family members and all other persons whom they had contact with will also be protected.15
An important finding from this study was that about 50% of study participants with good knowledge of MDR-TB were reported  using the N-95 mask which was higher compared 
to those with insufficient level of knowledge, 
however, this result did not reach statistically 
significant. This finding suggested that any interventions which purpose to increase the level of knowledge about MDR-TB might lead to better compliance about preventive measures among HCWs.This study revealed that 89.5% of study participants were involved in giving health education about MDR-TB to TB patients. Besides, several studies showed that there are some issues related to MDR-TB treatment which may introduce poor treatment outcomes. Some factors were associated with loss-to-follow up such as 1) lack of social support; 2) dissatisfaction with HCWs attitudes; 3) unstable socioeconomic status; 4) lack of counselling; and 5) poor response to therapy.16–19 Moreover, qualitative studies showed the severe side effects of MDR-TB treatment were described to be “as bad as or worse than the illness itself”.20 Therefore, health education and adequate counselling related to MDR treatment especially about duration of injectable phase and total duration, also potential adverse events should be given thoroughly by HCWs to MDR-TB patients.
Another finding in this study was a 
significant moderate correlation (r=0.44) between the level of knowledge and attitude among HCWs with regard to MDR-TB. This demonstrated that educational intervention about MDR-TB combined with availability of protective equipment and monitoring practices based on clinical management guideline would support consistent behavior among HCWs towards its implementation. Moreover, systematic training and regular workshop about MDR-TB for HCWs  should be conducted for improving their knowledge. A series of profesional seminars about MDR-TB for general practitioners or nurses could be a good media to distribute current update on diagnosis and treatment of this disease. Regular monitoring to health care facilities should help check HCW’s compliance regarding MDR-TB management.Furthermore, this study noticed some limitations like less variations of healthcare professionals since general practitioners, pharmacists, and counsellors had not been included. The study participants were asked about knowledge and attitude but their current practice with regard to MDR-TB were not measured comprehensively. Another limitation was that this study was a cross-sectional survey; thus causal relationships could not be established.In conclusion, the level of knowledge among 
Althea Medical Journal. 2016;3(4)
513
HCWs about MDR-TB is still at an unacceptable level. Certain educational interventions aim to ensure prompt diagnosis, implement infection control and accurate treatment should be established among HCWs to make a success of PMDT
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